Manish A. Kohli MD, MBBS

Dr. Manish Kohli graduated in 1990 from the University of Delhi with Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as a Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in the metastatic castrate-resistant stage. In 2005, he joined the University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy-based research.

In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program, and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, and also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor.

Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focuses on “convergence sciences” which combines population-based trials with precision medicine concepts.